|
⚲
|
| Keyboard |
| Mereo Biopharma Group PLC | |
|---|---|
| Ticker | MREO |
| CIK # | 0001719714 |
| CUSIP | 589492107 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | One Cavendish Place Fourth Floor, London, W1G0QF |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Mereo Biopharma Group PLC | 2020-06-12 | 70.0 M | Exemption: 506(b) · Minimum: $1 · Duration: One year or less · Commission: $4,200,000 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001719714] | 10-K | |
| [0001719714] | 10-Q | |
| [0001719714] | 3 | |
| [0001719714] | 4 | |
| [0001719714] | 6-K | |
| [0001719714] | 8-K | |
| [0001719714] | D | |
| [0001719714] | SC 13D | |
| [0001719714] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Yoskowitz Marc J
Share Options (Right to buy) · derivative
|
2026-02-26 | Grant | 66,000 | $0.00 | |
|
Yoskowitz Marc J
Deferred Restricted Stock Units · derivative
|
2026-02-26 | Grant | 96,163 | ||
|
Jacquet Pierre
Share Options (Right to buy) · derivative
|
2026-02-26 | Grant | 66,000 | $0.00 | |
|
Jacquet Pierre
Deferred Restricted Stock Units · derivative
|
2026-02-26 | Grant | 106,848 | ||
|
Jenkins Annalisa
Share Options (Right to buy) · derivative
|
2026-02-26 | Grant | 66,000 | $0.00 | |
|
Jenkins Annalisa
Deferred Restricted Stock Units · derivative
|
2026-02-26 | Grant | 106,848 | ||
|
Shames Daniel
Share Options (Right to buy) · derivative
|
2026-02-26 | Grant | 66,000 | $0.00 | |
|
Shames Daniel
Deferred Restricted Stock Units · derivative
|
2026-02-26 | Grant | 96,163 | ||
|
Bender Jeremy
Deferred Restricted Stock Units · derivative
|
2026-02-26 | Grant | 117,533 | ||
|
Ekblom Anders
Share Options (Right to buy) · derivative
|
2026-02-26 | Grant | 66,000 | $0.00 | |
|
Ekblom Anders
Deferred Restricted Stock Units · derivative
|
2026-02-26 | Grant | 133,560 | ||
|
Bender Jeremy
Share Options (Right to buy) · derivative
|
2026-02-26 | Grant | 66,000 | $0.00 | |
|
Pakianathan Deepika
Share Options (Right to buy) · derivative
|
2026-02-26 | Grant | 66,000 | $0.00 | |
|
Wyzga Michael S
Share Options (Right to buy) · derivative
|
2026-02-26 | Grant | 66,000 | $0.00 | |
|
Lewicki John A
Share Options (Right to buy) · derivative
|
2026-02-01 | Grant | 46,637 | $0.00 | |
|
Lewicki John A
Share Options (Right to buy) · derivative
|
2026-02-01 | Grant | 139,913 | $0.00 | |
|
Lewicki John A
Share Options (Right to buy) · derivative
|
2026-02-01 | Grant | 145,000 | $0.00 | |
|
Hughes-Wilson Alexandra
Share Options (Right to buy) · derivative
|
2026-02-01 | Grant | 61,250 | $0.00 | |
|
Hughes-Wilson Alexandra
Share Options (Right to buy) · derivative
|
2026-02-01 | Grant | 183,750 | $0.00 | |
|
Hughes-Wilson Alexandra
Share Options (Right to buy) · derivative
|
2026-02-01 | Grant | 195,000 | $0.00 | |
| showing 20 of 139 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 64 | 76,277,137 |
| 2025-12-31 | 74 | 66,742,428 |
| 2025-09-30 | 87 | 102,452,945 |
| 2025-06-30 | 90 | 101,585,985 |
| 2025-03-31 | 91 | 112,769,972 |
| 2024-12-31 | 92 | 115,754,824 |
| 2024-09-30 | 78 | 106,115,993 |
| 2024-06-30 | 80 | 100,617,222 |
| 2024-03-31 | 81 | 87,260,767 |
| 2023-12-31 | 66 | 78,989,124 |
| 2023-09-30 | 57 | 70,648,060 |
| 2023-06-30 | 55 | 64,825,061 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Significant Wealth Partners LLC | [2026-06-30] | SOLE | 0 | 32,677 |
| Gamma Investing LLC | [2026-06-30] | DFND | 9,308 | 9,308 | Prev | Page 1 | Next |